Published research characterized thymosin beta-4 as a small peptide that binds single actin monomers (G-actin) and holds them out of filaments. Biochemical studies from 1991 to 1993 reported that it inhibited polymerization, bound ATP-actin about 50-fold more tightly than ADP-actin, and handed monomers to profilin, which delivered them to growing filament ends. A 1992 study estimated roughly 149 micromolar of the peptide in resting human neutrophils. All of this work is in vitro and cell-based.
Why is actin the starting point for thymosin beta-4 research?
Actin exists as single monomers, called G-actin, and as assembled filaments, called F-actin. Thymosin beta-4 (Tβ4) is a roughly 5-kDa polypeptide originally identified in calf thymus (source 2), and its link to actin was established in 1991, when a study in the Journal of Biological Chemistry reported that it was indistinguishable from Fx, an actin-sequestering peptide that had been isolated earlier, and that it bound actin and inhibited its polymerization in vitro (source 1).
Nearly everything published about the material sold as TB-500 traces back to this actin-binding role of full-length Tβ4. The Steadfast Research Group overview of what research says about TB-500 introduces the compound, and the companion post on TB-500 mechanism of action research surveys the later signaling proposals. This post stays with the actin biochemistry itself: how much Tβ4 cells contain, how tightly it binds, how it cooperates with profilin, and what structural studies showed about the contact. None of the studies below tested a synthetic TB-500 fragment, and none describe an outcome in people.
What does it mean that thymosin beta-4 "sequesters" G-actin?
A sequestering protein binds actin monomers and keeps them from joining filaments, creating a reserve of unpolymerized actin that the cell can draw on later. The 1991 study framed Tβ4 in exactly these terms (source 1). A 1992 study in Proceedings of the National Academy of Sciences then tested the idea in living cells: the researchers microinjected synthetic Tβ4 into cultured epithelial cells and fibroblasts and reported loss of stress fibers and a dose-dependent depolymerization of actin filaments, concluding that the peptide was a potent regulator of actin polymerization in living cells (source 2).
A 1997 biophysical study in Biochemistry summarized the field's working model in its abstract: Tβ4 binds actin monomers stoichiometrically and maintains the bulk of the actin monomer pool in metazoan cells (source 8). Stoichiometric binding means one peptide engages one monomer, so the size of the sequestered pool depends on how much Tβ4 a cell contains.
How much thymosin beta-4 do cells contain?
That question was measured directly in white blood cells. A 1992 study in the Journal of Cell Biology quantified Tβ4 in resting human polymorphonuclear leukocytes (neutrophils) and reported about 169 fg per cell (SD 90 fg), which the authors converted to a cytoplasmic concentration of roughly 149 micromolar (SD 80.5) (source 4). The paper's title states its conclusion: Tβ4 sequestered the majority of G-actin in those resting cells.
Platelets were the other early model. A 1992 study in Biochemistry compared how Tβ4 interacted with muscle actin and with platelet actin, and its title framed the results in terms of actin sequestration in resting platelets (source 3). Together, the neutrophil and platelet work moved Tβ4 from a peptide that could bind actin in a test tube to one present at concentrations high enough to account for a large share of the unpolymerized actin in those cell types.
Does the nucleotide bound to actin change how thymosin beta-4 binds?
Each actin monomer carries a bound nucleotide, either ATP or ADP. A 1993 study in Proceedings of the National Academy of Sciences compared the magnesium-bound forms and reported that Tβ4 had a 50-fold higher affinity for MgATP-actin than for MgADP-actin, and the authors proposed that the ATP/ADP ratio could therefore modulate how much actin Tβ4 holds (source 6).
A 1992 study in Molecular Biology of the Cell examined the same question from the opposite direction, asking how fast the nucleotide on a bound monomer could be swapped. The authors reported that Tβ4 strongly inhibited nucleotide exchange on actin, while profilin catalytically promoted it, and they presented the pairing as a potential regulatory mechanism for actin polymerization in cells (source 5).
How do thymosin beta-4 and profilin divide the work?
Profilin is a separate actin-monomer binding protein, and much of the Tβ4 literature is really about how the two interact. A 1993 study in Cell reported that Tβ4 kept monomeric actin from joining filaments but took part in exchanging actin with profilin (source 7). In the authors' model, profilin acted as a polymerization catalyst: it captured an actin monomer, carried it onto the growing barbed end of a filament as a 1:1 profilin-actin complex, and was then released.
On that model, the Tβ4-bound reserve was not a dead end. Monomers could pass from Tβ4 to profilin and from profilin onto the barbed ends of filaments, so a large sequestered pool and active filament growth could coexist in the same system (source 7).
A 2014 structural study in Proceedings of the National Academy of Sciences examined how that hand-off works at the molecular level (source 13). Its first crystal structure showed Tβ4 with two helices bound at the barbed and pointed faces of G-actin, a placement that blocked the bound monomer from incorporating into a filament. Combining further structures with biochemical assays and molecular dynamics simulations, the authors reported that exchange of actin between Tβ4 and profilin involved both steric and allosteric components.
What did structural studies show about the binding itself?
Structural work on the complex had to contend with a peptide that is not rigid on its own. The 1997 Biochemistry study reported that Tβ4 bound actin in an extended conformation that contacted both the barbed and pointed ends of the monomer (source 8). A 2004 nuclear magnetic resonance study in the Journal of Biological Chemistry examined the coupling of folding and binding: Tβ4 was flexible in aqueous solution and adopted a stable conformation, including two helices, only when bound to actin (source 10).
A 2004 crystallography study in The EMBO Journal took a protein-engineering route, fusing the C-terminal half of Tβ4 to gelsolin domain 1 (source 11). The authors reported that this hybrid sequestered actin monomers, severed actin filaments and acted as a leaky barbed-end cap, and the paper presented its structure in the context of WH2 domains, an actin-interacting motif found in both monomer-sequestering and filament-assembly proteins (source 11).
Which parts of the sequence matter most for actin binding?
A 2008 mutagenesis study in Biochemistry substituted alanine for seven residues spread along Tβ4 (Pro4, Lys18, Lys19, Pro27, Leu28, Pro29 and Ile34) and measured binding to MgATP-actin monomers (source 12). Substituting Lys18 and Lys19, Leu28, Pro29 or Ile34 weakened the affinity of the actin-Tβ4 complex at least 10-fold. Substituting Pro4 or Pro27 changed affinity by no more than 3-fold but accelerated both binding and dissociation, and the authors suggested that cis-trans isomerization of these prolines contributed to the slow association rate of the unmodified peptide. The paper's title summarized the finding: widely distributed residues in Tβ4 were critical for actin binding.
How do the key findings compare?
| Study (year, journal) | System | What researchers reported |
|---|---|---|
| Safer et al. (1991, J Biol Chem) | Purified protein | Tβ4 indistinguishable from Fx; bound actin and inhibited polymerization (source 1) |
| Sanders et al. (1992, PNAS) | Microinjected cultured cells | Loss of stress fibers; dose-dependent filament depolymerization (source 2) |
| Cassimeris et al. (1992, J Cell Biol) | Resting human neutrophils | About 169 fg per cell, roughly 149 micromolar; majority of G-actin sequestered (source 4) |
| Goldschmidt-Clermont et al. (1992, Mol Biol Cell) | Purified proteins | Tβ4 strongly inhibited nucleotide exchange; profilin promoted it (source 5) |
| Carlier et al. (1993, PNAS) | Purified proteins | 50-fold higher affinity for MgATP-actin than MgADP-actin (source 6) |
| Pantaloni and Carlier (1993, Cell) | Purified proteins | Actin exchanged from Tβ4 to profilin, which delivered it to barbed ends (source 7) |
| Domanski et al. (2004, J Biol Chem) | NMR in solution | Flexible alone; folded, with two helices, on binding actin (source 10) |
| Au et al. (2008, Biochemistry) | Alanine mutants | Five substitutions weakened affinity at least 10-fold (source 12) |
| Xue et al. (2014, PNAS) | Crystal structures and simulations | Helices at barbed and pointed faces; steric and allosteric exchange with profilin (source 13) |
How does thymosin beta-4 relate to the wider WH2 family?
Tβ4 belongs to a family of short actin-binding modules, the β-thymosin/WH2 domains, which occur in proteins that sequester monomers and in proteins that assemble filaments (source 11). A 2004 study in Cell examined the structural basis for the switch from inhibition to promotion of actin assembly within this family, linking the switch to a change in how the central and C-terminal regions of the domain interact with subdomains 1 and 2 of G-actin (source 9). That work framed sequestration, the behavior reported for Tβ4, and promotion of assembly as two outcomes available to the same kind of domain.
What are the limits of the actin evidence?
The scope of the actin evidence is narrow. Many measurements used purified proteins, including muscle actin, under defined in vitro conditions (sources 3, 5, 6, 7); the cell measurements came from a small number of cell types, chiefly neutrophils, platelets and cultured fibroblasts and epithelial cells (sources 2, 3, 4). The 2004 crystal structure relied on an engineered gelsolin hybrid rather than native Tβ4 alone (source 11). And every study here used full-length Tβ4 or defined mutants of it. Whether a shorter synthetic fragment sold as TB-500 reproduces the binding constants, nucleotide preference or profilin exchange reported for the full peptide was not tested in any of the cited work, and the affinity drops reported for residues spread across the sequence (source 12) are a reason not to assume it.
For laboratories working with Tβ4-related research material, that gap is the main reading point: the actin biochemistry describes a well-characterized natural peptide, and it is a starting hypothesis for any related synthetic sequence, not a measured property of it.
Frequently asked questions
What is the difference between G-actin and F-actin?
G-actin is the single, globular actin monomer, and F-actin is the filament formed when monomers assemble end to end. Thymosin beta-4 was characterized as binding G-actin and inhibiting its assembly into filaments in the 1991 Journal of Biological Chemistry study and the 1992 PNAS microinjection study.
Is thymosin beta-4 the same protein as profilin?
No. Both bind actin monomers, but they are different proteins with different roles in the published model. A 1993 Cell study described thymosin beta-4 as keeping monomers out of filaments and profilin as carrying monomers onto growing filament ends, with actin exchanged between the two.
Why did researchers use hybrid proteins to solve the structure?
A 2004 NMR study reported that thymosin beta-4 was flexible in solution and only adopted a stable shape when bound to actin. The 2004 EMBO Journal study fused the C-terminal half of thymosin beta-4 to gelsolin domain 1 and solved the structure of that hybrid bound to actin, an engineering approach rather than a structure of the native peptide alone.
What does MgATP-actin mean?
It refers to an actin monomer carrying a bound ATP nucleotide together with a magnesium ion; MgADP-actin carries ADP instead. A 1993 PNAS study reported that thymosin beta-4 bound MgATP-actin with 50-fold higher affinity than MgADP-actin.
Was any of the actin research done on TB-500 itself?
No. The studies summarized here used full-length thymosin beta-4 or defined alanine mutants of it. A 2008 Biochemistry study found that residues spread across the whole sequence affected binding strength, so results for the full peptide cannot be assumed for a shorter synthetic fragment.
Research sources
- Safer D, Elzinga M, Nachmias VT, “Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable,” Journal of Biological Chemistry 266(7):4029–4032 (1991)
- Sanders MC, Goldstein AL, Wang YL, “Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells,” Proceedings of the National Academy of Sciences 89(10):4678–4682 (1992)
- Weber A, Nachmias VT, Pennise CR, Pring M, Safer D, “Interaction of thymosin beta 4 with muscle and platelet actin: implications for actin sequestration in resting platelets,” Biochemistry 31(27):6179–6185 (1992)
- Cassimeris L, Safer D, Nachmias VT, Zigmond SH, “Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes,” Journal of Cell Biology 119(5):1261–1270 (1992)
- Goldschmidt-Clermont PJ, Furman MI, Wachsstock DH, Safer D, Nachmias VT, Pollard TD, “The control of actin nucleotide exchange by thymosin beta 4 and profilin. A potential regulatory mechanism for actin polymerization in cells,” Molecular Biology of the Cell 3(9):1015–1024 (1992)
- Carlier MF, Jean C, Rieger KJ, Lenfant M, Pantaloni D, “Modulation of the interaction between G-actin and thymosin beta 4 by the ATP/ADP ratio: possible implication in the regulation of actin dynamics,” Proceedings of the National Academy of Sciences 90(11):5034–5038 (1993)
- Pantaloni D, Carlier MF, “How profilin promotes actin filament assembly in the presence of thymosin beta 4,” Cell 75:1007–1014 (1993)
- Safer D, Sosnick TR, Elzinga M, “Thymosin beta 4 binds actin in an extended conformation and contacts both the barbed and pointed ends,” Biochemistry 36:5806–5816 (1997)
- Hertzog M, van Heijenoort C, Didry D, et al., “The beta-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assembly,” Cell 117:611–623 (2004)
- Domanski M, Hertzog M, Coutant J, et al., “Coupling of folding and binding of thymosin β4 upon interaction with monomeric actin monitored by nuclear magnetic resonance,” Journal of Biological Chemistry 279:23637–23645 (2004)
- Irobi E, Aguda AH, Larsson M, et al., “Structural basis of actin sequestration by thymosin-β4: implications for WH2 proteins,” The EMBO Journal 23(18):3599–3608 (2004)
- Au JK, Olivares AO, Henn A, Cao W, Safer D, De La Cruz EM, “Widely distributed residues in thymosin β4 are critical for actin binding,” Biochemistry 47(13):4181–4188 (2008)
- Xue B, Leyrat C, Grimes JM, Robinson RC, “Structural basis of thymosin-β4/profilin exchange leading to actin filament polymerization,” Proceedings of the National Academy of Sciences 111(43):E4596–E4605 (2014)